SpringWorks Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$103M
Industry:Biotech
Founded:2017
Lead Investor(s):N/A

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • SpringWorks Therapeutics's estimated annual revenue is currently $11.8M per year.
  • SpringWorks Therapeutics received $103.0M in venture funding in September 2017.
  • SpringWorks Therapeutics's estimated revenue per employee is $155,000
  • SpringWorks Therapeutics's total funding is $103M.

Employee Data

  • SpringWorks Therapeutics has 76 Employees.
  • SpringWorks Therapeutics grew their employee count by 27% last year.
  • SpringWorks Therapeutics currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Brainstorm Cell...
N/A22N/AN/A-N/A
Empire Genomics
N/A30N/AN/A-N/A
North Central B...
$48.8M3155%N/A-N/A
Enzo Biochem
N/A33N/AN/A-N/A
Axsome Therapeu...
$4.8M340%N/A-N/A
Progenics Pharm...
$20.8M13416%N/A-N/A
Regeneron Pharm...
N/A9849N/AN/A-N/A
Sartorius Stedi...
$19.8M12825%N/A-N/A
Outlook Therape...
$8.4M54100%N/A-N/A
Envisagenics
$2.8M18N/AN/A-N/A
Missing a competitor? Contribute!?
Submit

SpringWorks Therapeutics is a mission-driven medicines company dedicated to developing innovative potential new treatments for unserved and underserved patient communities. Originally conceived by Pfizer, SpringWorks presents a groundbreaking new model for collaboration rooted in connecting scientists, biopharmaceutical partners, patient groups, funders and philanthropists to advance and deliver transformative science to patients. Through our partnerships, we remain focused on providing innovative treatments an additional avenue for development, with our launch pipeline focused on advancing potential programs for four diseases, all of which currently have no cure, including desmoid tumor, neurofibromatosis, hereditary xerocytosis and post-traumatic stress disorder. Our name is a reflection of our approach to drug development: we're springing into action to deliver treatments to people who are in great need and without alternatives.

keywords:N/A

76

Number of Employees

$11.8M

Revenue (est)

1

Current Jobs

27%

Employee Growth %

$103M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

SpringWorks Therapeutics News

12-Sep-19 - Stamford's SpringWorks Therapeutics debuts IPO today

Stamford biopharmaceutical company SpringWorks Therapeutics Inc. has priced its initial public offering of 9 million shares of its common stock ...

12-Sep-19 - Springworks Therapeutics IPO: What You Need To Know

Stamford, Connecticut-based Springworks Therapeutics, Inc. has filed with the SEC for offering 9 million shares of its common stock, upsized ...

12-Sep-19 - SpringWorks Therapeutics Announces Pricing Of Initial Public ...

STAMFORD, Conn., Sept. 12, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a clinical-stage biopharmaceutical company ...

SpringWorks Therapeutics Funding

DateAmountRoundLead InvestorsReference
2017-09-26$103.0MAMultipleArticle

SpringWorks Therapeutics Executive Hires

DateNameTitleReference
2018-09-06Saqib IslamCEOArticle